Literature DB >> 12358954

Effect of xenon on cerebral autoregulation in pigs.

M Schmidt1, T Marx, C Papp-Jambor, U Schirmer, H Reinelt.   

Abstract

There are little data on the effect of anaesthetic concentrations of xenon on cerebral pressure autoregulation. In this study, we have investigated the effect of 79% xenon inhalation on cerebral pressure autoregulation and CO2 response in pigs. Ten pigs were randomly allocated to receive xenon 79% or halothane anaesthesia, respectively, in a crossover designed study. Halothane was used to validate the experimental set-up. Transcranial Doppler was performed to determine the mean flow velocities in the middle cerebral artery (vMCA) during defined cerebral perfusion pressures and during normo-, hyper- and hypoventilation. The results showed that the inhalation of 79% xenon preserved cerebral autoregulation during conditions of normo-, hyper- and hypoventilation and at different cerebral perfusion pressures in pigs. These results suggest that with the inhalation of xenon, in the highest concentration suitable for a safe clinical use, cerebral autoregulation is preserved.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12358954     DOI: 10.1046/j.1365-2044.2002.02862.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  3 in total

Review 1.  [Current developments in xenon research. Importance for anesthesia and intensive care medicine].

Authors:  A Brücken; M Coburn; S Rex; R Rossaint; M Fries
Journal:  Anaesthesist       Date:  2010-10       Impact factor: 1.041

2.  Effects of xenon and hypothermia on cerebrovascular pressure reactivity in newborn global hypoxic-ischemic pig model.

Authors:  Elavazhagan Chakkarapani; John Dingley; Kristian Aquilina; Damjan Osredkar; Xun Liu; Marianne Thoresen
Journal:  J Cereb Blood Flow Metab       Date:  2013-07-31       Impact factor: 6.200

Review 3.  Update of the organoprotective properties of xenon and argon: from bench to beside.

Authors:  Roehl Anna; Rossaint Rolf; Coburn Mark
Journal:  Intensive Care Med Exp       Date:  2020-02-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.